Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Canwell Pharma, Inc.
February 27, 2026
Canwell Pharma, Inc.
Orphan Drug Designation
Wellesley
1-50 employees
treatment of soft tissue sarcoma
Disease Area:
Rare Disease
Source
Scroll to Top